Literature DB >> 11533659

Nuclear localization of EGF receptor and its potential new role as a transcription factor.

S Y Lin1, K Makino, W Xia, A Matin, Y Wen, K Y Kwong, L Bourguignon, M C Hung.   

Abstract

Epidermal growth factor receptor (EGFR) has been detected in the nucleus in many tissues and cell lines. However, the potential functions of nuclear EGFR have largely been overlooked. Here we demonstrate that nuclear EGFR is strongly correlated with highly proliferating activities of tissues. When EGFR was fused to the GAL4 DNA-binding domain, we found that the carboxy terminus of EGFR contained a strong transactivation domain. Moreover, the receptor complex bound and activated AT-rich consensus-sequence-dependent transcription, including the consensus site in cyclin D1 promoter. By using chromatin immunoprecipitation assays, we further demonstrated that nuclear EGFR associated with promoter region of cyclin D1 in vivo. EGFR might therefore function as a transcription factor to activate genes required for highly proliferating activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533659     DOI: 10.1038/ncb0901-802

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  403 in total

1.  Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.

Authors:  Konstantin H Dragnev; Tian Ma; Jobin Cyrus; Fabrizio Galimberti; Vincent Memoli; Alexander M Busch; Gregory J Tsongalis; Marc Seltzer; David Johnstone; Cherie P Erkmen; William Nugent; James R Rigas; Xi Liu; Sarah J Freemantle; Jonathan M Kurie; Samuel Waxman; Ethan Dmitrovsky
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  Characterization of nuclear neurokinin 3 receptor expression in rat brain.

Authors:  C D Sladek; W Stevens; S R Levinson; Z Song; D D Jensen; F W Flynn
Journal:  Neuroscience       Date:  2011-09-08       Impact factor: 3.590

3.  CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.

Authors:  Nozomu Sakai; Hiroyuki Yoshidome; Takashi Shida; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Dan Takeuchi; Masahiro Sakakibara; Masaru Miyazaki
Journal:  Clin Exp Metastasis       Date:  2011-11-11       Impact factor: 5.150

4.  Subcellular localization of epidermal growth factor receptor in human submandibular gland.

Authors:  M S Lantini; M Cossu; M Isola; M Piras; M Piludu
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

5.  Localization of importin alpha (Rch1) at the plasma membrane and subcellular redistribution during lymphocyte activation.

Authors:  Ricardo Andrade; Raúl Alonso; Raúl Peña; Jon Arlucea; Juan Aréchaga
Journal:  Chromosoma       Date:  2003-07-15       Impact factor: 4.316

Review 6.  On the molecular basis of the receptor mosaic hypothesis of the engram.

Authors:  Luigi F Agnati; Sergi Ferré; Giuseppina Leo; Carme Lluis; Enric I Canela; Rafael Franco; Kjell Fuxe
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

7.  Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope.

Authors:  Zhaocai Zhou; Xiulian Du; Zheng Cai; Xiaomin Song; Hongtao Zhang; Takako Mizuno; Emi Suzuki; Marla Rosanne Yee; Alan Berezov; Ramachandran Murali; Shiaw-Lin Wu; Barry L Karger; Mark I Greene; Qiang Wang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 8.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

9.  Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.

Authors:  Yingqiu Xie; Wenfu Lu; Shenji Liu; Qing Yang; Brett S Carver; Estelle Li; Yuzhuo Wang; Ladan Fazli; Martin Gleave; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2014-08-06

10.  Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells.

Authors:  Richard S Beard; Ricci J Haines; Kevin Y Wu; Jason J Reynolds; Stephanie M Davis; John E Elliott; Nikolay L Malinin; Victor Chatterjee; Byeong J Cha; Mack H Wu; Sarah Y Yuan
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.